Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...

The Phase I/II LIGHTHOUSE trial is assessing the safety and tolerability of the gene therapy in male subjects.

In this Healio Video Perspective from the ESCRS winter meeting, Harminder S. Dua, MD, PhD, professor of ophthalmology at the University of Nottingham, discusses the implications of Dua’s layer in ...